1. The drafting history of the European biotechnology directive;
2. Towards commonality? policy approaches to human embryonic stem cell research in Europe;
3. Human embryonic stem cell research in Central and Eastern Europe: a comparative analysis of regulatory and policy approaches;
4. Morality provisions in law concerning the commercialization of human embryos and stem cells;
5. A comparative analysis of the national implementation of the directive's morality clause;
6. The construction of the directive's moral exclusions under the EPC;
7. Towards systemic legal conflict: article 6(2) (c) of the EU directive on biotechnological inventions;
8. Human dignity, human rights, and article 6(1) of the EU directive on biotechnological inventions;
9. Institutional and jurisdictional aspects of stem cell patenting in Europe (EC and EPO): tensions and prospects;
10. A transnational institution confronted with a single jurisdiction model: guidance for the EPO's implementation of the directive from a private international law perspective;
11. An ethics committee for patent offices?
12. The research exemption in patent law and its application to hESC research;
13. Human embryos, patents, and global trade: assessing the scope and contents of the TRIPS morality exception;
14. Stem cells patenting and competition law.